Head and Neck Squamous Cell Carcinoma Clinical Trials in Ramat Gan
3 recruitingRamat Gan, Israel
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients
Head and Neck Squamous Cell Carcinoma
Merus B.V.500 enrolled207 locationsNCT06496178
Recruiting
Phase 3
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Head and Neck Squamous Cell Carcinoma
Merus B.V.500 enrolled185 locationsNCT06525220
Recruiting
Not Applicable
A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC
Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaSkin Cancer
Alpha Tau Medical LTD.48 enrolled3 locationsNCT05047094